Abstract
Purpose of reviewProvide an update on current management and most recent evidence in the treatment of pediatric pericarditis.Recent findingsWhile treatment of acute pericarditis has not significantly changed over the last decade, management of recurrent acute pericarditis, with increased attention to autoinflammation as a causal mechanism, has evolved substantially. This includes clinical trial evidence that newer medications targeting interleukin-1 receptors are effective in recurrent forms of pericarditis. In addition, advanced imaging utilizing cardiac magnetic resonance has emerged as a particularly effective way to detect ongoing pericardial inflammation in support of more difficult-to-treat patients.SummaryRecent advances in acute and recurrent pericarditis management have allowed for a more tailored approach to the individual patient. Yet, unresolved questions require further research.
Original language | English (US) |
---|---|
Pages (from-to) | 364-368 |
Number of pages | 5 |
Journal | Current Opinion in Cardiology |
Volume | 38 |
Issue number | 4 |
DOIs | |
State | Published - Jul 1 2023 |
Externally published | Yes |
Keywords
- immunotherapies
- pericarditis
- recurrent pericarditis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine